IL17A and neoplasm: In patients with a below median number of intra-tumoral IL-17+ non-T cells, a high tumor-infiltrating T cell frequency was correlated with improved disease-free and disease-specific survival, suggesting that a high frequency of IL-17+ cells is related to a poor immune response.